COVID-19的影像学表现:CT、MRI与PET
本文综述了COVID-19在CT、MRI和PET上的影像学表现。胸部CT是诊断和监测COVID-19进展及并发症的核心手段,典型表现为双肺外周、后部分布的磨玻璃影和网状影,可伴实变。MRI与CT对COVID-19肺炎典型特征显示高度一致,适用于需避免电离辐射的患者;PET并非一线诊断手段,但可偶然发现肺部病灶摄取,且在需核医学检查的无症状患者中可能最早提示感染。
要点
- 胸部CT典型表现为双肺外周、后部分布磨玻璃影和网状影,可伴实变。
- 肺MRI与胸部CT显示COVID-19肺炎典型特征高度一致,可用于孕妇和儿童。
- PET/CT诊断COVID-19特异性差,受成本、辐射和检查时间限制,非一线手段。
核心结论
- 胸部CT仍是COVID-19初始诊断、进展监测和并发症评估的核心影像手段。
- 肺MRI与胸部CT对COVID-19肺炎典型特征显示高度一致,可作为需避免电离辐射患者的替代选择。
- PET/CT因特异性差、成本、辐射负担和检查时间长,不用于COVID-19原发检测,但可偶然发现肺部病灶摄取。
研究设计与样本
- 本文为综述,汇总COVID-19在CT、MRI和PET上的影像学表现及相关研究数据。
主要发现
- 胸部CT经典特征包括磨玻璃影和网状影,可伴或不伴实变,常呈双侧、外周和后部分布。
- MRI研究显示与胸部CT在显示COVID-19肺炎典型特征方面高度一致。
- 多项报告注意到PET放射性示踪剂在COVID-19相关肺部病灶实质区的偶然定位。
- 中东呼吸综合征-CoV队列数据提示18F-FDG PET可在无明确感染临床征象的受试者中检测亚临床感染和淋巴结炎。
临床怎么用
- 对需避免电离辐射的患者,尤其孕妇和儿童,可考虑肺MRI替代胸部CT。
- 因其他临床指征行核医学检查时,PET可能最早发现无症状个体的新生感染。
- 对合并恶性肿瘤和免疫抑制患者,及时识别感染并早期启动支持治疗对改善生存至关重要。
局限性
- PET/CT用于COVID-19原发检测受限于特异性差、成本、辐射负担和成像人员长时间暴露。
- 扫描机架消毒耗时,扫描室充分通风可能需长达一小时停机以完成足够空气交换。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Soon after reports of a novel coronavirus capable of causing severe pneumonia surfaced in late 2019, expeditious global spread of the Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV-2) forced the World Health Organization to declare an international state of emergency. Although best known for causing symptoms of upper respiratory tract infection in mild cases and fulminant pneumonia in severe disease, Coronavirus Disease 2019 (COVID-19) has also been associated with gastrointestinal, neurologic, cardiac, and hematologic presentations. Despite concerns over poor specificity and undue radiation exposure, chest imaging nonetheless remains central to the initial diagnosis and monitoring of COVID-19 progression, as well as to the evaluation of complications. Classic features on chest CT include ground-glass and reticular opacities with or without superimposed consolidations, frequently presenting in a bilateral, peripheral, and posterior distribution. More recently, studies conducted with MRI have shown excellent concordance with chest CT in visualizing typical features of COVID-19 pneumonia. For patients in whom exposure to ionizing radiation should be avoided, particularly pregnant patients and children, pulmonary MRI may represent a suitable alternative to chest CT. Although PET imaging is not typically considered among first-line investigative modalities for the diagnosis of lower respiratory tract infections, numerous reports have noted incidental localization of radiotracer in parenchymal regions of COVID-19-associated pulmonary lesions. These findings are consistent with data from Middle East Respiratory Syndrome-CoV cohorts which suggested an ability for 18F-FDG PET to detect subclinical infection and lymphadenitis in subjects without overt clinical signs of infection. Though highly sensitive, use of PET/CT for primary detection of COVID-19 is constrained by poor specificity, as well as considerations of cost, radiation burden, and prolonged exposure times for imaging staff. Even still, decontamination of scanner bays is a time-consuming process, and proper ventilation of scanner suites may additionally require up to an hour of downtime to allow for sufficient air exchange. Yet, in patients who require nuclear medicine investigations for other clinical indications, PET imaging may yield the earliest detection of nascent infection in otherwise asymptomatic individuals. Especially for patients with concomitant malignancies and other states of immunocompromise, prompt recognition of infection and early initiation of supportive care is crucial to maximizing outcomes and improving survivability.
引用
- Fields BKK, Demirjian NL, Dadgar H, et al. Imaging of COVID-19: CT, MRI, and PET. Semin Nucl Med. 2020. PMID: 33288215. doi:10.1053/j.semnuclmed.2020.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。